Cargando…
Response to Dr. Masaya Miyauchi and Dr. Teruhiko Imamura, Clinical implication of COVID‐19 associated bradycardia
Autores principales: | Kumar, Sabina, Arcuri, Christina, Chaudhuri, Sumanta, Gupta, Rahul, Aseri, Mahendra, Barve, Pranav, Shah, Shivang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364719/ https://www.ncbi.nlm.nih.gov/pubmed/34240749 http://dx.doi.org/10.1002/clc.23675 |
Ejemplares similares
-
Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021) -
A novel study on SARS‐COV‐2 virus associated bradycardia as a predictor of mortality‐retrospective multicenter analysis
por: Kumar, Sabina, et al.
Publicado: (2021) -
A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients
por: Umeh, Chukwuemeka, et al.
Publicado: (2022) -
The volumes of Miyauchi subgroups
por: Lesesvre, Didier, et al.
Publicado: (2022) -
Safety of ACEi and ARB in COVID‐19 management: A retrospective analysis
por: Kumar, Sabina, et al.
Publicado: (2022)